271 related articles for article (PubMed ID: 27289559)
1. Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.
Najafi Z; Saeedi M; Mahdavi M; Sabourian R; Khanavi M; Tehrani MB; Moghadam FH; Edraki N; Karimpor-Razkenari E; Sharifzadeh M; Foroumadi A; Shafiee A; Akbarzadeh T
Bioorg Chem; 2016 Aug; 67():84-94. PubMed ID: 27289559
[TBL] [Abstract][Full Text] [Related]
2. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
Saeedi M; Rastegari A; Hariri R; Mirfazli SS; Mahdavi M; Edraki N; Firuzi O; Akbarzadeh T
Chem Biodivers; 2020 May; 17(5):e1900746. PubMed ID: 32154628
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives.
Rastegari A; Nadri H; Mahdavi M; Moradi A; Mirfazli SS; Edraki N; Moghadam FH; Larijani B; Akbarzadeh T; Saeedi M
Bioorg Chem; 2019 Mar; 83():391-401. PubMed ID: 30412794
[TBL] [Abstract][Full Text] [Related]
7. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates].
Luo W; Huang K; Zhang Z; Hong C; Wang CJ
Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel chromenones linked to 1,2,3-triazole ring system: Investigation of biological activities against Alzheimer's disease.
Saeedi M; Safavi M; Karimpour-Razkenari E; Mahdavi M; Edraki N; Moghadam FH; Khanavi M; Akbarzadeh T
Bioorg Chem; 2017 Feb; 70():86-93. PubMed ID: 27914694
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities.
Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ
Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094
[TBL] [Abstract][Full Text] [Related]
12. Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment.
Czarnecka K; Szymański P; Girek M; Mikiciuk-Olasik E; Skibiński R; Kabziński J; Majsterek I; Malawska B; Jończyk J; Bajda M
Bioorg Chem; 2017 Jun; 72():315-322. PubMed ID: 28501648
[TBL] [Abstract][Full Text] [Related]
13. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.
Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M
Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873
[TBL] [Abstract][Full Text] [Related]
14. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Luo XT; Wang CM; Liu Y; Huang ZG
Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer's disease.
Wang Y; Yang Y; Hong KH; Ning Y; Yu P; Ren J; Ji M; Cai J
Bioorg Chem; 2019 Jun; 87():720-727. PubMed ID: 30954836
[TBL] [Abstract][Full Text] [Related]
16. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
17. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
[TBL] [Abstract][Full Text] [Related]
18. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Xu R; Cao Z; Song Q; Wang T; Zhang X; Liu H; Tan Z; Deng Y
Eur J Med Chem; 2017 Jul; 135():307-323. PubMed ID: 28458136
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment.
Zhu J; Wang LN; Cai R; Geng SQ; Dong YF; Liu YM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1325-1329. PubMed ID: 30956012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
